Haemonetics Corporation
HAE Real Time Price USDRecent trades of HAE by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by HAE's directors and management
* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.
- 1M
- 3M
- 6M
- YTD
- 1Y
- 2Y
- 5Y
- MAX
About
Key Metrics
Return (1d)
Return (30d)
Return (1Y)
CAGR (Total)
Max Drawdown
Beta
Alpha
Sharpe Ratio
Win Rate
Average Win
Average Loss
Annual Volatility
Annual Std Dev
Information Ratio
Treynor Ratio
Total Trades
Metrics Definitions
-
Alpha
Measures a portfolio's risk-adjusted performance against that of its benchmark
Learn More -
Annual Standard Deviation
Measures how much the portfolio's total return varies from its mean or average.
Learn More -
Annual Volatility
A statistical measure of the dispersion of returns for the portfolio.
Learn More -
Average Win
The average return (%) for trades that resulted in a positive return.
-
Average Loss
The average return (%) for trades that resulted in a negative return.
-
Beta
A measure of the volatility of the portfolio compared to the market as a whole.
Learn More -
CAGR
CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.
Learn More -
Information Ratio
A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.
Learn More -
Max Drawdown
the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.
Learn More -
Sharpe Ratio
The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.
Learn More -
Total Trades
The total number of trades made by this strategy.
-
Treynor Ratio
Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.
Learn More -
Win Rate
The percentage of total trades that resulted in a positive return.
Be the first to see our newest insights and key updates across all datasets.
Government lobbying spending instances
-
$40,000 Jan 27, 2014 Issue: Health Issues
-
$40,000 Oct 16, 2013 Issue: Health Issues
-
$40,000 Jul 24, 2013 Issue: Health Issues
-
$40,000 Apr 08, 2013 Issue: Health Issues
-
$40,000 Jan 22, 2013 Issue: Health Issues
-
$20,000 Jan 14, 2013 Issue: Health Issues
-
$60,000 Dec 27, 2012 Issue: Health Issues
Estimated quarterly lobbying spending
HAE Revenue by Segment or Geography
New patents grants
Federal grants, loans, and purchases
- $22,660 2025-06-05 00:00:00 Agency: Department of Veterans Affairs
- $12,166 2025-02-19 00:00:00 Agency: Department of Health and Human Services
- $73,686 2024-10-17 00:00:00 Agency: Department of Veterans Affairs
- $8,148 2024-10-03 00:00:00 Agency: Department of Veterans Affairs
- $4,074 2024-09-16 00:00:00 Agency: Department of Veterans Affairs
- $4,074 2024-09-16 00:00:00 Agency: Department of Veterans Affairs
- $6,496 2024-04-30 00:00:00 Agency: Department of Health and Human Services
- $22,000 2023-08-07 00:00:00 Agency: Department of Health and Human Services
- $4,021 2023-05-05 00:00:00 Agency: Department of Veterans Affairs
- $46,895 2023-02-15 00:00:00 Agency: DEPARTMENT OF HEALTH AND HUMAN SERVICES (HHS)
- $176,441 2022-11-16 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
- $30,631 2022-08-29 00:00:00 Agency: DEPARTMENT OF DEFENSE (DOD)
- $12,942 2022-08-23 00:00:00 Agency: DEPARTMENT OF DEFENSE (DOD)
- $49,074 2022-07-22 00:00:00 Agency: DEPARTMENT OF DEFENSE (DOD)
- $11,538 2022-07-12 00:00:00 Agency: DEPARTMENT OF HEALTH AND HUMAN SERVICES (HHS)
- $21,561 2022-05-16 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
- $0 2022-02-23 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
- $849 2021-09-29 00:00:00 Agency: DEPARTMENT OF DEFENSE (DOD)
- $29,623 2021-09-07 00:00:00 Agency: DEPARTMENT OF DEFENSE (DOD)
- $23,972 2021-09-01 00:00:00 Agency: DEPARTMENT OF DEFENSE (DOD)
- $4,000 2021-07-20 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
- $4,270 2021-07-15 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
- $25,995 2021-06-02 00:00:00 Agency: DEPARTMENT OF DEFENSE (DOD)
- $854 2021-05-07 00:00:00 Agency: DEPARTMENT OF DEFENSE (DOD)
- $641 2021-05-06 00:00:00 Agency: DEPARTMENT OF DEFENSE (DOD)
- $44,000 2021-04-20 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
- $733 2021-02-11 00:00:00 Agency: DEPARTMENT OF DEFENSE (DOD)
Estimated quarterly amount awarded from public contracts
Recent insights relating to HAE
Recent picks made for HAE stock on CNBC
ETFs with the largest estimated holdings in HAE
- ... Highest Price Target
- ... Median Price Target
- ... Lowest Price Target
|
Analyst
|
Firm
|
Current
|
Previous
|
Date
|
|---|
- Is $HAE stock a Buy, Sell, or Hold?
- What is the price target for $HAE stock?
* Analyst consensus is not financial advice. Please see our data disclaimers .
|
Shareholder
|
Shares Held
|
|---|
- Who owns $HAE stock?
- Who owns the most shares of $HAE stock?
- What funds own $HAE stock?
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view HAE Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.